Related Experiment Videos
[The coronary hyperemic reaction in scleroderma]
Insights
Systemic scleroderma patients show reduced coronary hyperemic reaction, indicating impaired small artery dilation in the heart. This vascular anomaly may contribute to scleroderma cardiomyopathy.
Area of Science:
- Cardiology
- Vascular Biology
- Rheumatology
Context:
- Systemic scleroderma is associated with functional, organic, and vascular anomalies.
- Primitive sclerodermatous cardiomyopathy is a cardiac manifestation of systemic scleroderma.
- Coronary hyperemic reaction assesses the heart's vascular function.
Purpose:
- To investigate the coronary hyperemic reaction in patients with primitive sclerodermatous cardiomyopathy.
- To identify specific vascular anomalies contributing to the condition.
Summary:
- The coronary hyperemic reaction, a transient increase in coronary flow post-contrast injection, was significantly diminished in scleroderma patients compared to controls.
- This limitation reflects an impaired ability of coronary arterioles to dilate in affected individuals.
- The findings highlight a critical vascular dysfunction in scleroderma cardiomyopathy.
Impact:
- Reveals a key vascular mechanism potentially underlying primitive sclerodermatous cardiomyopathy.
- Suggests impaired coronary microvascular function as a significant factor in systemic scleroderma.
- Provides insights for potential therapeutic targets to improve cardiac outcomes in scleroderma.
Abstract:
Functional, organic and vascular anomalies could play an important role in systemic scleroderma. We have studied the coronary hyperemic reaction in subjects with primitive sclerodermatous cardiomyopathy, in order to specify the vascular anomalies. The coronary hyperemic reaction consists of a transient rise in coronary flow after selective injection of a contrast agent into the left coronary artery. In sclerodermatous subjects this coronary hyperemic reaction is significantly smaller than in control subjects. This limitation of the hyperemic reaction reflects a decrease in the ability of small arteries or coronary arterioles to dilate in sclerodermatous subjects. This anomaly could play an important role in primitive sclerodermatous cardiomyopathy.